Search
Search Results
##search.searchResults.foundPlural##
-
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6498PDF: 2226HTML: 14161Untitled: 243figure: 225 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1432PDF: 497HTML: 18633Figure 1: 202Figure 2: 186Figure 3: 198Figure 4: 231Figure 5: 206 -
-
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1515PDF: 615HTML: 244 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2594HTML: 323PDF: 963 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1486PDF: 743HTML: 1191Untitled: 218Untitled: 182Untitled: 171Untitled: 188Untitled: 203 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1643PDF: 829HTML: 2206Untitled: 262Untitled: 240Untitled: 236Untitled: 252Untitled: 249 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2316PDF: 1692HTML: 652 -
RECENT ADVANCES IN THE 5Q- SYNDROME
3067PDF: 1920HTML: 3828Pellagatti Fig 1: 263Pellagatti Fig. 2: 250 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1703PDF: 1124HTML: 492 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2477PDF: 1934HTML: 182 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5884PDF: 1596HTML: 1668Untitled: 276 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1768PDF: 1155HTML: 174 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1715PDF: 778HTML: 1488 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
840PDF: 600HTML: 290 -
Simultaneous dual pathology in lymph node
1732PDF: 756HTML: 7850Simultaneous dual pathology in lymph node: 211Simultaneous dual pathology in lymph node: 220Simultaneous dual pathology in lymph node: 183Simultaneous dual pathology in lymph node: 227Simultaneous dual pathology in lymph node: 219 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2618PDF: 1257HTML: 1087 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2881PDF: 1027HTML: 4735 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5169PDF: 1366HTML: 1939Untitled: 227Untitled: 211 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2418PDF: 1062HTML: 7707Untitled: 321Fig2: 221Fig3: 215Fig4: 232 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4431PDF: 2014HTML: 5530Table 1: 259 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4627PDF: 1549HTML: 8546 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1471PDF: 744HTML: 1393cover letter: 248 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2726PDF: 1245HTML: 287







